foxo4-dri senolytic peptide human trial 2024 2025 Frontiers Peptide Inhibitors Targeting FOXO4-p53 Interactions
Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Buy FOXO4 DRI 10mg Third Party Tested BioEdge Peptides FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC
Pay in 4 interest-free payments of $6.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




